|
Aug. 06, 2024 |
|
|
Aug. 06, 2024 |
|
|
jRCT1030240253 |
Stratum corneum sampling study for validation of analytical method for drug concentration in human stratum corneum |
|
Stratum corneum sampling study for validation of analytical method for drug concentration in human stratum corneum |
Takazawa Kenji |
||
Medical Corporation Shinanokai Shinanozaka Clinic |
||
3F Yotsuya Medical Building, 20 Samoncho, Shinjuku-ku, Tokyo |
||
+81-3-5366-3006 |
||
m-kinomoto@trcp.co.jp |
||
Kinomoto Mikito |
||
Tokyo Research Center of Clinical Pharmacology Co., Ltd. |
||
Yotsuya Medical Building, 20 Samoncho, Shinjuku-ku, Tokyo |
||
+81-3-5366-3006 |
||
m-kinomoto@trcp.co.jp |
Pending |
July. 29, 2024 |
||
| 6 | ||
Observational |
||
single arm study |
||
open(masking not used) |
||
uncontrolled control |
||
single assignment |
||
other |
||
(1) Age: 20 to 40 years old (at the time of obtaining consent) |
||
Persons with have skin wounds at the site of stratum corneum collection, and those who have skin symptoms such as eczema, contact dermatitis, psoriasis, seborrheic dermatitis, dyschromatosis, and excessive sunburn at the site of stratum corneum collection. |
||
| 20age old over | ||
| 40age old under | ||
Male |
||
Pain relief and anti-inflammation |
||
Stratum corneum sampling |
||
none |
||
| Lead Chemical Co., Ltd. |
| Medical Corporation Shinanokai Shinanozaka Clinic Ethics Committee | |
| Yotsuya Medical Building, 20 Samoncho, Shinjuku-ku, Tokyo, Tokyo | |
+81-3-5366-3006 |
|
| scl-irb@shinanokai.com | |
| Approval | |
July. 23, 2024 |
No |
none |